According to reports, ILK is overexpressed in colorectal cancer, bladder cancer, and many other tumor tissue types and is associated with TNM (‘tumor,’ ‘nodes,’ and ‘metastasis’) stage, lymph node metastasis, and differentiation, thus indicating ILK as a potential anti-cancer therapeutic target [9–12]. The gene discussed is ILK; the disease is urinary bladder carcinoma.